New draft guidance (“Draft Guidance”) from the U.S. Food and Drug Administration (“FDA”) and the Office for Human Research Protections (“OHRP”) strongly highlights the need for Institutional Review Boards (“IRBs”) overseeing human subject research to keep detailed minutes of their meetings. Doing so, according to the Draft Guidance, will demonstrate to the IRBs’ research institutions…Read More
Department of Health and Human Services Issues Draft Guidance on Preparing Adequate IRB Minutes
Posted on November 30, 2015 in Health Law News
Published by: Hall Render